Business An experimental COVID drug was so successful that they’re shutting down trials early Published 3 years ago on 12 April 2022 By Terry Power Share Tweet Experimental COVID drug sabizabulin cuts mortality rate in half for severe cases | Fortune You need to enable JavaScript to view this site. Related Topics:COVIDdrugearlyexperimentalshuttingsuccessfulTheyretrials Up Next Crypto expert gets 63-month prison sentence for helping North Korea evade U.S. sanctions Don't Miss Investment banks say inflation has peaked, but small businesses are still raising prices Continue Reading You may like A chemo drug storage shows the vulnerability of the healthcare supply chains Who gets to decide who receives experimental medical treatments? Decoding the data of the Chinese mpox outbreak China is suddenly dealing with another public health crisis: mpox Covid hasn’t entirely gone away—here’s where we stand 2 Cancer Drug Trials Put On Hold After 6 Participants Died During Testing Business These fast-growing Sun Belt cities suffer from high inflation Published 3 years ago on 4 May 2022 By Terry Power U.S. migration hotspots tend to have the highest inflation | Fortune You need to enable JavaScript to view this site. Continue Reading Business The U.S. is seizing a $325 million helipad-equipped megayacht in Fiji. The question is which Russian oligarch it belongs to Published 3 years ago on 4 May 2022 By Terry Power Oligarch sanctions: U.S. seizing $325 million megayacht in Fiji. The question is which Russian billionaire it belongs to | Fortune You need to enable JavaScript to view this site. Continue Reading Business Investors bank on today’s ‘once-in-a-generation’ Fed hike to be one of several Published 3 years ago on 4 May 2022 By Terry Power Fed rate hike: decision day rattles markets as investors worry that a giant ‘once-in-a-generation’ hike will be one of several this year | Fortune You need to enable JavaScript to view this site. Continue Reading